Opportunity Information: Apply for PA 18 288

The grant opportunity titled Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional), Funding Opportunity Number PA 18 288, is a National Institutes of Health (NIH) discretionary grant designed to support early-stage, exploratory research aimed at improving real-world health outcomes for people affected by deafness and other human communication disorders. It sits within the mission areas of the National Institute on Deafness and Other Communication Disorders (NIDCD), meaning it is focused on conditions and services related to hearing, balance, smell, taste, voice, speech, and language. The emphasis is not simply on whether an intervention can work under ideal circumstances, but on effectiveness and health services research, which typically looks at how interventions, care models, or delivery systems perform in everyday clinical and community settings, how accessible they are, and how they can be implemented in ways that measurably improve patient outcomes.

This funding uses the NIH R21 mechanism, which generally supports novel, high-impact ideas and pilot work that can generate preliminary evidence, test approaches, or develop methods that could later be scaled into larger studies. The FOA is labeled “Clinical Trial Optional,” meaning applicants may propose studies that include clinical trials if appropriate, but they are not required to do so. In practice, this opens the door to a wide range of projects, including pragmatic trials, implementation studies, comparative effectiveness studies, evaluations of care pathways, or research that examines barriers and facilitators to adopting evidence-based practices in audiology, speech-language pathology, otolaryngology, vestibular care, and related service systems.

The opportunity is categorized under Health (Funding Activity Category) and is associated with CFDA number 93.173. The listed award ceiling is $200,000, which signals that the program is meant to fund smaller, targeted projects rather than large multi-site efforts. While the source information does not specify the number of expected awards, the R21 structure and the ceiling indicate the program is oriented toward focused, time-limited studies that can demonstrate feasibility, generate effect size estimates, validate measures, or provide actionable evidence to improve service delivery and outcomes in NIDCD-relevant populations.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, city or township governments, special district governments, and independent school districts. Higher education institutions are eligible, including public and state-controlled institutions and private institutions of higher education. Tribal entities are included both as federally recognized Native American tribal governments and as Native American tribal organizations other than federally recognized tribal governments. Housing-related public authorities, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations other than small businesses, and small businesses are also listed as eligible. In addition, the FOA explicitly highlights other eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; and U.S. territories or possessions. This breadth is consistent with the FOA’s applied, outcomes-oriented focus, since improving communication health outcomes often depends on partnerships across clinical systems, schools, community organizations, and public programs.

Foreign eligibility is restricted in a specific way. Non-domestic (non-U.S.) entities (foreign organizations) and non-domestic (non-U.S.) institutions are not eligible to apply as primary applicants. Non-domestic components of U.S. organizations are also not eligible to apply. However, “foreign components,” as defined by the NIH Grants Policy Statement, are allowed. This typically means a U.S. applicant organization can include certain defined international elements in the project (for example, a specific collaborating site, population, or resource outside the U.S.) when justified scientifically, while still keeping the applicant organization and core project administration U.S.-based.

The FOA was created on 2017-11-02, and the original closing date listed is 2020-05-07. Overall, the opportunity is best understood as a targeted NIH/NIDCD funding route for practical, outcomes-driven research that can make care for communication disorders more effective, more accessible, and more implementable in real settings, with the flexibility to include clinical trials when that is the right tool for the research question.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173.
  • This funding opportunity was created on 2017-11-02.
  • Applicants must submit their applications by 2020-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 18 288

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R21- Clinical Trial Not Allowed)

Previous opportunity: Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) - Clinical Trial Not Allowed

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 18 288

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 18 288) also looked into and applied for these:

Funding Opportunity
Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1409A

Funding Number: CDC RFA GH14 1409A
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: Case Dependent
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R03 Clinical Trial Required) Apply for PA 18 198

Funding Number: PA 18 198
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required) Apply for PA 18 197

Funding Number: PA 18 197
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 021

Funding Number: RFA AG 18 021
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03 Clinical Trial Optional) Apply for PA 18 200

Funding Number: PA 18 200
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R03 Clinical Trial Optional) Apply for PA 18 201

Funding Number: PA 18 201
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R21 Clinical Trial Optional) Apply for PA 18 202

Funding Number: PA 18 202
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R01 Clinical Trial Required) Apply for PA 18 192

Funding Number: PA 18 192
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01 Clinical Trial Optional) Apply for PA 18 193

Funding Number: PA 18 193
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01 Clinical Trial Optional) Apply for PA 18 194

Funding Number: PA 18 194
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21 Clinical Trial Optional) Apply for PA 18 199

Funding Number: PA 18 199
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed) Apply for RFA MD 18 002

Funding Number: RFA MD 18 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
NIMH Exploratory/Developmental Research Grant (R21 - Clinical Trial Not Allowed) Apply for PA 18 350

Funding Number: PA 18 350
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Selected Topics in Transfusion Medicine (R01 Clinical Trial Optional) Apply for PAR 18 126

Funding Number: PAR 18 126
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Translational Neural Devices (UG3/UH3 - Clinical Trial Required) Apply for RFA NS 18 011

Funding Number: RFA NS 18 011
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) Apply for PAR 18 174

Funding Number: PAR 18 174
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Selected Topics in Transfusion Medicine (R21 Clinical Trial Optional) Apply for PAR 18 132

Funding Number: PAR 18 132
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Translational Neural Devices (U44 - Clinical Trial Required) Apply for RFA NS 18 012

Funding Number: RFA NS 18 012
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) (Clinical Trial Required) Apply for RFA HL 18 027

Funding Number: RFA HL 18 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Human Subjects Mechanistic and Minimal Risk Studies (R01 Clinical Trial Optional) Apply for PA 18 351

Funding Number: PA 18 351
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 288", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: